Trieu Vuong bought OTLC

July 9, 2025 · Form 4 insider transaction

Trieu Vuong bought 1 shares of Oncotelic Therapeutics, Inc. at $0.01 per share, a transaction worth $0.01. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.